Literature DB >> 23518015

Antifungal activity, SAR and physicochemical correlation of some thiazole-1,3,5-triazine derivatives.

U P Singh1, H R Bhat, P Gahtori.   

Abstract

OBJECTIVE: Present research communication was towards the investigation of antifungal minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) activity of some substituted clubbed thiazole-1,3,5-triazines derivatives and effect of physicochemical properties on bioactivity.
MATERIAL AND METHODS: MIC and MFC were evaluated against Candida albicans, Candida glabrata, Cryptococcus neoformans and Aspergillus niger using modified microdilution method recommended by CLSI. Cytotoxicity was determinate on the viability of marine shrimp larvaes. SAR and physicochemical correlations were studied by Molinspiration software.
RESULTS: The 5 and 9 derivatives showed an excellent antifungal activity with MIC lower than fluconazole and equivalent to amphotericin B specially against C. albicans and C. glabrata. The toxicity of these two derivatives was non-existent for 5 and moderate for 9 at the used concentration. SAR study around prototype molecule suggests that presence of di-hydrophobic fragment on 1,3,5-triazine is necessary for antifungal activity than halogen substituted aromatic amine.
CONCLUSION: On the basis of selectivity, potency and non-toxicity, we have obtained two molecules (5 and 9) as prospective leads for further research work on 1,3,5-triazine as antifungal drug.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23518015     DOI: 10.1016/j.mycmed.2011.12.073

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  9 in total

Review 1.  Transition metal-free one-pot synthesis of nitrogen-containing heterocycles.

Authors:  Simpal Kumari; Dharma Kishore; Sarvesh Paliwal; Rajani Chauhan; Jaya Dwivedi; Aakanksha Mishra
Journal:  Mol Divers       Date:  2015-06-09       Impact factor: 2.943

Review 2.  Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents.

Authors:  Panpan Zhang; Shutao Ma
Journal:  Medchemcomm       Date:  2019-05-27       Impact factor: 3.597

3.  Facile Synthesis, Characterization, and In Vitro Antimicrobial Screening of a New Series of 2,4,6-Trisubstituted-s-triazine Based Compounds.

Authors:  Ravi Bhushan Singh; Nirupam Das; Md Kamaruz Zaman
Journal:  Int J Med Chem       Date:  2015-01-31

4.  Hybrid phenylthiazole and 1,3,5-triazine target cytosolic leucyl-tRNA synthetase for antifungal action as revealed by molecular docking studies.

Authors:  Udaya Pratap Singh; Hans Raj Bhat; Prashant Gahtori; Ramendra K Singh
Journal:  In Silico Pharmacol       Date:  2013-02-12

5.  Anti‑breast cancer activity of selected 1,3,5‑triazines via modulation of EGFR‑TK.

Authors:  Weixin Yan; Yiyang Zhao; Jianrong He
Journal:  Mol Med Rep       Date:  2018-08-24       Impact factor: 2.952

6.  Exploring the Orthogonal Chemoselectivity of 2,4,6-Trichloro-1,3,5-Triazine (TCT) as a Trifunctional Linker With Different Nucleophiles: Rules of the Game.

Authors:  Anamika Sharma; Ayman El-Faham; Beatriz G de la Torre; Fernando Albericio
Journal:  Front Chem       Date:  2018-11-01       Impact factor: 5.221

7.  Cationic Amphipathic Triazines with Potent Anti-bacterial, Anti-inflammatory and Anti-atopic Dermatitis Properties.

Authors:  Pethaiah Gunasekaran; Ganesan Rajasekaran; Eun Hee Han; Young-Ho Chung; Young-Jin Choi; Yu Jin Yang; Ji Eun Lee; Hak Nam Kim; Kiram Lee; Jin-Seok Kim; Hyun-Jun Lee; Eun-Ju Choi; Eun-Kyung Kim; Song Yub Shin; Jeong Kyu Bang
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

8.  Utilisation of Home Laundry Effluent (HLE) as a catalyst for expeditious one-pot aqueous phase synthesis of highly functionalised 4-thiazolidinones.

Authors:  Udaya Pratap Singh; Hans Raj Bhat; Mukesh Kumar Kumawat; Ramendra K Singh
Journal:  Springerplus       Date:  2013-09-16

9.  Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase.

Authors:  Jitendra Kumar Srivastava; Girinath G Pillai; Hans Raj Bhat; Amita Verma; Udaya Pratap Singh
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.